Sleeping Sickness

9 registered clinical trials studyying Sleeping Sickness.

Status	Trial	Sponsor	Phase
Withdrawn	Screen and Treat Implementation for HAT Control NCT05645822	Institute of Tropical Medicine, Belgium	—
Completed	Pharmacokinetic, Efficacy, Safety and Tolerability Study of a Single Dose of Acoziborole in g-HAT Paediatric P NCT05433350	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Prospective Evaluation of the Specificity of Serological Tests for Human African Trypanosomiasis NCT05466630	Institut de Recherche pour le Developpement	N/A
Completed	Safety and Tolerability Study of Acoziborole in g-HAT Seropositive Subjects NCT05256017	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Fexinidazole in Human African Trypanosomiasis Due to T. b. Rhodesiense NCT03974178	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Diagnostic Tools for Human African Trypanosomiasis Elimination and Clinical Trials: WP3 Post Elimination Monit NCT04099628	Institut de Recherche pour le Developpement	N/A
Completed	Fexinidazole in Human African Trypanosomiasis Due to T.b. Gambiense at Any Stage NCT03025789	Drugs for Neglected Diseases	Phase 3
Completed	Efficacy and Safety of Acoziborole (SCYX-7158) in Patients With Human African Trypanosomiasis Due to T.b. Gamb NCT03087955	Drugs for Neglected Diseases	Phase 2 / Phase 3
Completed	Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2 NCT01685827	Drugs for Neglected Diseases	Phase 2 / Phase 3